BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1987
Size (employees)
200 (est)
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

CTO
Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
Alexander K. Arrow

Alexander K. Arrow

Chief Medical Officer
William E. Brown

William E. Brown

VP, Business Development
Colleen M. Boswell

Colleen M. Boswell

Vice President, Regulatory Affairs and Quality Assurance

Biolase Office Locations

Biolase has offices in Irvine, Miami, Denver, Seattle and in 11 other locations
Irvine, US
Chicago, US
Frankfurt, DE
Atlanta, US
Pittsburgh, US
Minneapolis, US
Portland, US
Jacksonville, US
Albany, US
Columbus, US
New York, US
San Ramon, US
Seattle, US
Denver, US
Miami, US

Biolase Metrics

Biolase Summary

Market capitalization

$84.5 m

Closing share price

$1.2
Biolase's current market capitalization is $84.5 m.

Biolase Financials

We estimate that Biolase's revenue is $51.8 m in 2016 which is a 6.9% increase from the previous period.
FY, 2013Y, 2014Y, 2015Y, 2016

Revenue

$56.4 m$47.7 m$48.5 m$51.8 m

Revenue growth, %

(15.5%)1.7%6.9%

Gross profit

$21.5 m

Operating expense total

$32.5 m

EBIT

($11 m)

Net Income

($11.5 m)

Operating cash flow

($1.1 m)

Biolase Market Value History

Biolase Job Categories

Biolase Online Presence

Biolase Company Life

You may also be interested in